Pacer Advisors’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.43M Buy
6,535
+2,852
+77% +$624K ﹤0.01% 1123
2025
Q1
$825K Sell
3,683
-2,097
-36% -$469K ﹤0.01% 1257
2024
Q4
$1.89M Sell
5,780
-2,862
-33% -$937K ﹤0.01% 1016
2024
Q3
$2.59M Buy
8,642
+68
+0.8% +$20.4K 0.01% 840
2024
Q2
$2.82M Buy
8,574
+1,303
+18% +$429K 0.01% 792
2024
Q1
$2.88M Sell
7,271
-78
-1% -$30.9K 0.01% 734
2023
Q4
$2.59M Sell
7,349
-427
-5% -$150K 0.01% 720
2023
Q3
$2.92M Sell
7,776
-1,033
-12% -$388K 0.01% 541
2023
Q2
$3.37M Buy
8,809
+1,786
+25% +$683K 0.01% 600
2023
Q1
$2.43M Buy
7,023
+6,282
+848% +$2.18M 0.01% 676
2022
Q4
$174K Sell
741
-1,625
-69% -$382K ﹤0.01% 2300
2022
Q3
$582K Buy
2,366
+58
+3% +$14.3K ﹤0.01% 699
2022
Q2
$698K Sell
2,308
-1,569
-40% -$475K 0.01% 616
2022
Q1
$1.59M Sell
3,877
-1,006
-21% -$413K 0.01% 690
2021
Q4
$2.29M Sell
4,883
-645
-12% -$302K 0.02% 741
2021
Q3
$2.35M Sell
5,528
-245
-4% -$104K 0.03% 632
2021
Q2
$2.07M Buy
5,773
+1,499
+35% +$538K 0.03% 614
2021
Q1
$1.2M Sell
4,274
-433
-9% -$122K 0.02% 692
2020
Q4
$1.33M Sell
4,707
-2,417
-34% -$685K 0.03% 579
2020
Q3
$1.96M Sell
7,124
-1,663
-19% -$457K 0.04% 424
2020
Q2
$2M Buy
8,787
+8,710
+11,312% +$1.98M 0.04% 364
2020
Q1
$13K Sell
77
-25,060
-100% -$4.23M ﹤0.01% 598
2019
Q4
$3.78M Sell
25,137
-2,366
-9% -$356K 0.17% 104
2019
Q3
$3.9M Sell
27,503
-2,117
-7% -$300K 0.09% 239
2019
Q2
$3.71M Buy
29,620
+29,502
+25,002% +$3.69M 0.09% 231
2019
Q1
$13K Sell
118
-89
-43% -$9.81K ﹤0.01% 712
2018
Q4
$20K Sell
207
-25,269
-99% -$2.44M ﹤0.01% 394
2018
Q3
$3.15M Buy
25,476
+2,201
+9% +$272K 0.12% 161
2018
Q2
$2.31M Buy
23,275
+3,187
+16% +$316K 0.1% 222
2018
Q1
$1.77M Buy
20,088
+2,211
+12% +$195K 0.1% 238
2017
Q4
$1.76M Buy
17,877
+7,270
+69% +$717K 0.12% 191
2017
Q3
$1.02M Buy
10,607
+1,348
+15% +$130K 0.09% 282
2017
Q2
$875K Sell
9,259
-396
-4% -$37.4K 0.09% 300
2017
Q1
$788K Buy
9,655
+1,549
+19% +$126K 0.1% 273
2016
Q4
$687K Buy
8,106
+385
+5% +$32.6K 0.1% 258
2016
Q3
$575K Buy
7,721
+742
+11% +$55.3K 0.09% 302
2016
Q2
$529K Buy
6,979
+5,837
+511% +$442K 0.08% 302
2016
Q1
$79K Buy
+1,142
New +$79K 0.02% 691